1970
DOI: 10.1055/s-0028-1095111
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic Effects of Butylbiguanide During Long Lasting Intravenous Glucose Infusion in Normal Human Subjects

Abstract: In a previous report, butylbiguanide was found to increase the oral glucose tolerance in normal human subjects, but left the K-value unchanged during rapid intravenous tolerance tests. The present report shows, that butylbiguanide increases the glucose tolerance of normal human subjects even when glucose is given intravenously over a long period of time (6-hour infusion). The radioimmunological serum insulin (lRI) was not significantly changed. The free fatty acids (FF A), however, were significantly lowered. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1975
1975
1975
1975

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 6 publications
0
2
0
Order By: Relevance
“…Another often stated assumption is that biguanides stimulate peripheral glucose utilization [7,8,19,21,22]. The mechanisms which might be involved are not clear.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Another often stated assumption is that biguanides stimulate peripheral glucose utilization [7,8,19,21,22]. The mechanisms which might be involved are not clear.…”
Section: Discussionmentioning
confidence: 99%
“…Biguanides are used mainly to treat the elderly obese diabetic. According to many investigators biguanides reduce the elevated blood glucose level [7,8,11,13,17,21,37], body weight [1,4,11,17,18,34,37,42] and glucose excretion in urine [11]. A concomitant reduction of elevated cholesterol [1], triglyceride and insulin levels [24,28,34] has been reported.…”
mentioning
confidence: 99%